Michael Mulqueen, VP Business Development will be presenting eTheRNA immunotherapies NV(@etherna_immuno) at the upcoming European Life Sciences CEO Forum.

e-Meet eTheRNA immunotherapies NV at #Sachs_ELSF

More info @ https://t.co/YXBF2fDncZ pic.twitter.com/z23SnaX4iU

— Sachs Associates (@SachsAssociates) January 28, 2021